← Back to Search

Cleaning and Disinfecting Solution

BL-3100-NBR03 for Refractive Errors

N/A
Waitlist Available
Research Sponsored by Bausch & Lomb Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Summary

This trial involves 340 participants who will wear special contact lenses daily for a period of time. The lenses will be replaced regularly to test their effectiveness and safety.

Eligible Conditions
  • Refractive Errors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Overall comfort averaged over all scheduled follow-up visits
Dental Deposits
The proportion of eyes with any slit-lamp findings greater than Grade 2 over all follow-up visits.
+1 more

Side effects data

From 2014 Phase 4 trial • 40 Patients • NCT01602692
40%
Nausea
10%
Vomiting
100%
80%
60%
40%
20%
0%
Study treatment Arm
Tumescent Solution With Dilute Epinephrine
Tumescent Solution With Dilute Lidocaine and Epinephrine

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BL-3100-NBR03Experimental Treatment1 Intervention
BL-3100-NBR03 multi-purpose solution
Group II: renu® Advanced FormulaActive Control1 Intervention
renu® Advanced Formula multi-purpose solution
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BL-3100-NBR03 multi-purpose solution
2023
N/A
~300

Find a Location

Who is running the clinical trial?

Bausch & Lomb IncorporatedLead Sponsor
252 Previous Clinical Trials
57,041 Total Patients Enrolled
6 Trials studying Refractive Errors
603 Patients Enrolled for Refractive Errors
Daniel DonatelloStudy DirectorBausch & Lomb Incorporated
4 Previous Clinical Trials
1,674 Total Patients Enrolled
~127 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top